Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
Return to: OCREVUS (ocrelizumab)
*****************************************************
#Post#: 2466--------------------------------------------------
Fulminant hepatitis associated w/Echovirus 25 during Ocrevus tre
atment...
By: agate Date: April 8, 2019, 7:03 pm
---------------------------------------------------------
I may be giving too much attention to rare, anecdotal instances
of adverse effects of the MS disease-modifying drugs, but here
is another one. This MS patient was taking Ocrevus but ended up
getting a liver transplant--and stopping the Ocrevus. This is
from JAMA Neurology (April 8, 2019), "Fulminant hepatitis
associated with Echovirus 25 during treatment with ocrelizumab
for multiple sclerosis":
http://bit.ly/2WXuNQ6
This is from the discussion:
[quote]
[font=Guardian TextSans Web]Because ocrelizumab is a novel,
high-efficacy disease-modifying therapy for MS, it will probably
be extensively used. However, it may impair clearance of
enterovirus infections via B-cell depletion. Thus, in the case
of compatible symptoms, tests should be conducted for
enteroviruses. Given the bimodal clinical presentation (ie, the
patient had a severe rebound of liver enzyme levels after
initial improvement), patients receiving ocrelizumab with
enteroviral infection need close follow-up.[/font]
[/quote]
#Post#: 2587--------------------------------------------------
Re: Fulminant hepatitis associated w/Echovirus 25 during Ocrevus
treatment...
By: ewizabeth Date: July 17, 2019, 10:54 am
---------------------------------------------------------
I was required to get tested for all forms of hepatitis prior to
starting Ocrevus so now I know why. I was completely negative on
all of them.
*****************************************************
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.